Skip to content

Anika Therapeutics ANIK Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Globus Medical logo
Globus MedicalGMED
Envista Holdings Corporation logo
Envista Holdings CorporationNVST

Other financials

Income statement

See full
Revenue$32.6M+15.6%
Net income$3.3M+183%
EPS (diluted)$0.24

Balance sheet

See full
Cash & equivalents$38.4M-27.8%
Total debt$25.7M+1.2%
Total equity$137.3M-7.0%
Total assets$183.5M-2.2%

Cash flow

See full
Operating cash flow-$684.0K-262%
CapEx$1.4M-1.2%
Free cash flow-$2.1M-28.8%

Valuation

See full
Market cap$199.85M+23.0%
P/S1.7×-0.1×

Profitability

See full
Net margin-3.4%-1.6pp
FCF margin0.5%

Returns & leverage

See full
Return on equity-2.9%-1.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.7×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Anika Therapeutics’s 8-K, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's payments to acquire property, plant, and equipment?
Anika Therapeutics (ANIK) reported payments to acquire property, plant, and equipment of $1.45M in Q2 2026.
How has Anika Therapeutics's payments to acquire property, plant, and equipment changed year-over-year?
Anika Therapeutics's payments to acquire property, plant, and equipment decreased by 1.2% year-over-year, from $1.47M to $1.45M.
What is the long-term trend for Anika Therapeutics's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Anika Therapeutics's payments to acquire property, plant, and equipment has grown at a 7.3% compound annual growth rate (CAGR), from $5.14M to $6.83M.